Atara Biotherapeutics (ATRA) Assets (QoQ) (2014 - 2026)

Atara Biotherapeutics (ATRA) Assets (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Atara Biotherapeutics 110.04 Mn 101.68 Mn 392,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.18%
Dec 31, 2025 -32.92%
Sep 30, 2025 -18.25%
Jun 30, 2025 -40.52%
Mar 31, 2025 -43.14%
Dec 31, 2024 -23.55%
Sep 30, 2024 21.68%
Jun 30, 2024 -29.04%
Mar 31, 2024 -0.14%
Dec 31, 2023 -12.33%
Sep 30, 2023 -23.39%
Jun 30, 2023 -18.42%
Mar 31, 2023 -19.75%
Dec 31, 2022 2.20%
Sep 30, 2022 -15.55%
Jun 30, 2022 9.78%
Mar 31, 2022 -15.13%
Dec 31, 2021 4.05%
Sep 30, 2021 -1.50%
Jun 30, 2021 -13.75%